Richard B. Gaynor

Statistics

Publications

133

Citations

16K

H-Index

Active since

1972

Affiliations

The University of Texas Southwestern Medical Center(Current)

University of California, Los Angeles

BioNTech (United States)

Eli Lilly (United States)

Richard B. Gaynor is an author at The University of Texas Southwestern Medical Center specializing in life sciences, molecular biology, and gene expression.

Publications per year

1972–2025

133

Publications

133

The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β

Min-Jean Yin, Yumi Yamamoto, Richard B. Gaynor · Nature · 1998 · 1.6K citations

Life Sciences, Immunology, Pharmacology +14

Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs

S.-H.I. Ou, F Wu, David Harrich et al. · Journal of Virology · 1995 · 760 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

Patrick A. Ott, Siwen Hu‐Lieskovan, Bartosz Chmielowski et al. · Cell · 2020 · 743 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression

Yumi Yamamoto, Udit Verma, Shashi Prajapati et al. · Nature · 2003 · 571 citations

Life Sciences, Cell Biology, Molecular Biology +14

Sulindac Inhibits Activation of the NF-κB Pathway

Yumi Yamamoto, Min-Jean Yin, Keng-Mean Lin et al. · Journal of Biological Chemistry · 1999 · 492 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +7

1–5 of 133